Advertisement
Advertisement

PTCT

PTCT logo

PTC Therapeutics, Inc.

85.86
USD
Sponsored
-3.69
-4.12%
Jul 10, 14:27 UTC -4
Open

PTCT Earnings Reports

Positive Surprise Ratio

PTCT beat 15 of 42 last estimates.

36%

Next Report

Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$298.92M
/
$0.26
Implied change from Q1 26 (Revenue/ EPS)
+9.68%
/
-966.67%
Implied change from Q2 25 (Revenue/ EPS)
+67.11%
/
-131.33%

PTC Therapeutics, Inc. earnings per share and revenue

On May 07, 2026, PTCT reported earnings of -0.03 USD per share (EPS) for Q1 26, beating the estimate of -0.47 USD, resulting in a 93.75% surprise. Revenue reached 272.55 million, compared to an expected 223.18 million, with a 22.12% difference. The market reacted with a +14.27% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 0.26 USD, with revenue projected to reach 298.92 million USD, implying an decrease of -966.67% EPS, and increase of 9.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, PTC Therapeutics, Inc. reported EPS of -$0.03, beating estimates by 93.75%, and revenue of $272.55M, 22.12% above expectations.
The stock price moved up 14.27%, changed from $64.49 before the earnings release to $73.69 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on 10 analysts, PTC Therapeutics, Inc. is expected to report EPS of $0.26 and revenue of $298.92M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement